A total of 76 Mergers & Acquisitions (M&A) deals (pending and completed) were announced in the Pharmaceuticals of the North America region, in the last twelve months resulting in a total deal value of over $89,275.6 million. In the LTM period, May 2022 turned out to be the most prolific in terms of deal size, with a total deal value of $15,853.4 million, resulting in an average deal value of $2,642.2 million during that month. On the other hand, the month of April 2022 was the most prolific in terms of deal volume, recording a total of 9 deals, resulting in an average deal value of $499.5 million during that month.
Of the 76 deals, the deal secured between Pfizer Inc and Biohaven Pharmaceutical Holding Company Ltd, was the largest M&A deal in the North America Pharmaceuticals sector, which was valued at $12,210.5 million and was completed on May 10, 2022. The second-largest deal was between Merck & Co Inc and Acceleron Pharma Inc, while the third-largest deal was between Danaher Corp and Aldevron LLC. The Merck & Co Inc-Acceleron Pharma Inc deal and the Danaher Corp-Aldevron LLC deal were valued at $11,500.0 million and $9,600.0 million, respectively. The fourth-largest deal was between Pfizer Inc-Arena Pharmaceuticals Inc valued at $6,700.0 million, whereas the deal between PerkinElmer Inc-Biolegend Inc valued at $5,250.0 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $45,260.5 million and accounted for nearly 50.70% of the total deals (by value) announced during the last twelve months. The North America region accounted for 71.56% of the total M&A deals done globally, and accounted for 22.22% of the total deal size on a global scale.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward